Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Non-cash Items (2017 - 2025)

BioCorRx's Non-cash Items history spans 9 years, with the latest figure at $1.6 million for Q3 2025.

  • For Q3 2025, Non-cash Items changed N/A year-over-year to $1.6 million; the TTM value through Sep 2025 reached $1.6 million, changed N/A, while the annual FY2023 figure was $1.8 million, 103.73% up from the prior year.
  • Non-cash Items for Q3 2025 was $1.6 million at BioCorRx, up from $1.5 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $1.8 million in Q4 2023 and bottomed at $813700.0 in Q1 2021.
  • The 5-year median for Non-cash Items is $866766.0 (2022), against an average of $1.0 million.
  • The largest annual shift saw Non-cash Items increased 0.67% in 2021 before it surged 103.73% in 2023.
  • A 5-year view of Non-cash Items shows it stood at $815351.0 in 2021, then increased by 6.31% to $866766.0 in 2022, then soared by 103.73% to $1.8 million in 2023, then plummeted by 47.11% to $934026.0 in 2024, then skyrocketed by 72.38% to $1.6 million in 2025.
  • Per Business Quant, the three most recent readings for BICX's Non-cash Items are $1.6 million (Q3 2025), $1.5 million (Q2 2025), and $934026.0 (Q1 2024).